Analyzing blood clotting in hospitalized COVID-19 patients with severe pneumonia
Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy
This study looks at how COVID-19 affects blood clotting in hospitalized patients with severe pneumonia to see if it can help improve their treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire, Amiens Academic / other |
| Locations | 1 site (Amiens) |
| Trial ID | NCT04377490 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate the relationship between hemostasis and inflammation in hospitalized patients suffering from COVID-19 and severe pneumonia. By utilizing venous ultrasound and blood samples, the study will assess the coagulation status and the risk of thromboembolic events in these patients. The research seeks to enhance understanding of how COVID-19 may increase the likelihood of blood clots, contributing to better management of complications associated with the disease.
Who should consider this trial
Good fit: Ideal candidates for this study are hospitalized patients diagnosed with COVID-19 infection.
Not a fit: Patients under 18 years old will not benefit from this study as they are excluded from participation.
Why it matters
Potential benefit: If successful, this study could lead to improved strategies for preventing thromboembolic events in COVID-19 patients.
How similar studies have performed: Other studies have indicated a significant relationship between COVID-19 and increased thromboembolic risk, suggesting that this approach is supported by existing evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * all patients hospitalized in Amiens Hospital with COVID-19 infection Exclusion Criteria: * patients\< 18 years
Where this trial is running
Amiens
- CHU Amiens — Amiens, France (Recruiting)
Study contacts
- Principal investigator: Michel Slama, Pr — CHU Amiens
- Study coordinator: Michel Slama, Pr
- Email: slama.michel@chu-amiens.fr
- Phone: (33)3 22 08 78 41
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.